• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

佩罗尼氏病男性患者的阴茎血管评估。

Penile vascular evaluation of men with Peyronie's disease.

作者信息

Lopez J A, Jarow J P

机构信息

Department of Urology, Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, North Carolina.

出版信息

J Urol. 1993 Jan;149(1):53-5. doi: 10.1016/s0022-5347(17)35997-9.

DOI:10.1016/s0022-5347(17)35997-9
PMID:8267684
Abstract

A penile vascular evaluation was performed upon 95 consecutive men with Peyronie's disease (19 potent and 76 impotent) and 100 consecutive impotent men without Peyronie's disease to gain further understanding of the pathophysiology of erectile dysfunction in patients with Peyronie's disease. Only 1 of the 19 potent patients with Peyronie's disease had abnormal arterial blood flow by duplex ultrasonography and none had evidence of veno-occlusive dysfunction by either duplex ultrasonography or dynamic infusion cavernosometry/cavernosography. In contrast, 36% of the impotent men with Peyronie's disease had abnormal arterial blood flow and 59% had evidence of veno-occlusive dysfunction. There was no significant difference in historical risk factors for impotence between the impotent patients with Peyronie's disease and the control population of impotent patients. However, the presence of veno-occlusive dysfunction in the control population (16%) was significantly less than that of the impotent Peyronie's disease patients (p < 0.001). Although patients with Peyronie's disease may suffer impotence due to arterial occlusive disease, our results indicate that the principal cause of impotence in this patient population is veno-occlusive dysfunction.

摘要

对95例连续性佩罗尼氏病患者(19例有勃起功能、76例无勃起功能)以及100例连续性无佩罗尼氏病的勃起功能障碍男性进行阴茎血管评估,以进一步了解佩罗尼氏病患者勃起功能障碍的病理生理学。19例有勃起功能的佩罗尼氏病患者中,仅1例经双功超声检查显示动脉血流异常,且无论是双功超声检查还是动态海绵体灌注测压/海绵体造影检查,均无静脉闭塞功能障碍的证据。相比之下,76例无勃起功能的佩罗尼氏病患者中,36%有动脉血流异常,59%有静脉闭塞功能障碍的证据。佩罗尼氏病无勃起功能患者与勃起功能障碍对照人群在导致勃起功能障碍的既往危险因素方面无显著差异。然而,对照人群中静脉闭塞功能障碍的发生率(16%)显著低于佩罗尼氏病无勃起功能患者(p<0.001)。虽然佩罗尼氏病患者可能因动脉闭塞性疾病而出现勃起功能障碍,但我们的结果表明,该患者群体勃起功能障碍的主要原因是静脉闭塞功能障碍。

相似文献

1
Penile vascular evaluation of men with Peyronie's disease.佩罗尼氏病男性患者的阴茎血管评估。
J Urol. 1993 Jan;149(1):53-5. doi: 10.1016/s0022-5347(17)35997-9.
2
The relationship between diabetes mellitus, impotence and veno-occlusive dysfunction in Peyronie's disease patients.佩罗尼氏病患者中糖尿病、阳痿与静脉闭塞功能障碍之间的关系。
Urol Int. 1998;60(2):101-4. doi: 10.1159/000030220.
3
The treatment of loss of penile rigidity associated with Peyronie's disease.佩罗尼氏病相关阴茎勃起功能丧失的治疗。
Scand J Urol Nephrol Suppl. 1996;179:147-50.
4
Penile vascular assessment using color duplex sonography in men with Peyronie's disease.在佩罗尼氏病男性患者中使用彩色双功超声进行阴茎血管评估。
J Urol. 1996 Apr;155(4):1270-3.
5
Color Doppler ultrasound assessment of penile vascular system in men with Peyronie's disease.佩罗尼氏病男性阴茎血管系统的彩色多普勒超声评估
Int J Impot Res. 2000 Oct;12(5):263-7. doi: 10.1038/sj.ijir.3900569.
6
Duplex ultrasound findings in men with Peyronie's disease.佩罗尼氏病男性患者的双功超声检查结果。
Urol Radiol. 1991;12(4):199-202. doi: 10.1007/BF02924008.
7
Penile duplex ultrasonography in men with Peyronie's disease: is it veno-occlusive dysfunction or poor cavernosal arterial inflow that contributes to erectile dysfunction?阴茎双功能超声检查在 Peyronie 病患者中的应用:是静脉闭塞性功能障碍还是海绵体动脉流入不良导致勃起功能障碍?
J Sex Med. 2011 Dec;8(12):3446-51. doi: 10.1111/j.1743-6109.2011.02501.x. Epub 2011 Oct 7.
8
Pre-operative assessment of Peyronie's disease using colour Doppler sonography.
Br J Urol. 1992 Jun;69(6):629-32. doi: 10.1111/j.1464-410x.1992.tb15635.x.
9
Evaluation of penile hemodynamic status and adjustment of treatment alternatives in Peyronie's disease.佩罗尼氏病患者阴茎血流动力学状态评估及治疗方案调整
Asian J Androl. 2002 Sep;4(3):187-90.
10
Peyronie's disease and erectile failure.
J Urol. 1983 Dec;130(6):1103-4. doi: 10.1016/s0022-5347(17)51706-1.

引用本文的文献

1
Stem-cell therapy for erectile dysfunction: a review of clinical outcomes.干细胞治疗勃起功能障碍:临床疗效评价。
Int J Impot Res. 2021 Apr;33(3):271-277. doi: 10.1038/s41443-020-0279-8. Epub 2020 Apr 29.
2
Antioxidant Mechanism of Xiaojin Pill () for Treatment of Peyronie's Disease in Rats Based on Matrix Metalloproteinases.小金丸()治疗大鼠阴茎硬结症的抗氧化机制基于基质金属蛋白酶。
Chin J Integr Med. 2019 Sep;25(9):671-676. doi: 10.1007/s11655-019-3203-7. Epub 2019 Oct 24.
3
All about Peyronie's disease.关于佩罗尼氏病的一切。
Asian J Urol. 2015 Apr;2(2):70-78. doi: 10.1016/j.ajur.2015.04.019. Epub 2015 Apr 16.
4
Effect of collagenase Clostridium histolyticum on penile vascular and morphological parameters in patients with Peyronie's disease.溶组织梭状芽孢杆菌胶原酶对佩罗尼氏病患者阴茎血管及形态学参数的影响。
Transl Androl Urol. 2017 Oct;6(5):894-898. doi: 10.21037/tau.2017.07.27.
5
Understanding the cellular basis and pathophysiology of Peyronie's disease to optimize treatment for erectile dysfunction.了解佩罗尼氏病的细胞基础和病理生理学以优化勃起功能障碍的治疗。
Transl Androl Urol. 2017 Feb;6(1):46-59. doi: 10.21037/tau.2016.11.01.
6
Prevalence, psychological impact, and risk factors of erectile dysfunction in patients with Peyronie's disease: a retrospective analysis of 309 cases.佩罗尼氏病患者勃起功能障碍的患病率、心理影响及危险因素:309例回顾性分析
Res Rep Urol. 2016 Jul 18;8:95-103. doi: 10.2147/RRU.S109319. eCollection 2016.
7
Effects of sildenafil treatment on patients with Peyronie's disease and erectile dysfunction.西地那非治疗伴发勃起功能障碍的 Peyronie 病患者的疗效观察。
Ir J Med Sci. 2014 Sep;183(3):449-53. doi: 10.1007/s11845-013-1036-5. Epub 2013 Nov 5.
8
US Imaging in Peyronie's Disease.佩罗尼氏病的美国成像技术
J Clin Imaging Sci. 2012;2:63. doi: 10.4103/2156-7514.103053. Epub 2012 Oct 31.
9
Surgery for Peyronie's disease.阴茎硬结症的手术治疗。
Asian J Androl. 2013 Jan;15(1):27-34. doi: 10.1038/aja.2012.92. Epub 2012 Nov 26.
10
Investigation of erectile dysfunction.勃起功能障碍的研究。
Br J Radiol. 2012 Nov;85 Spec No 1(Spec Iss 1):S69-78. doi: 10.1259/bjr/20361140.